Elisabeth Rosner, PhD, ERT

sr. Constant Toxicology / preclinical development

About

Extensive experience (>25 years) in all aspects of non-clinical safety (toxicology) from early discovery, research, clinical development and submission in drug development. I had the opportunity to manage both, small molecules and new modalities from target selection to market authorization in all aspects of toxicology. This includes health authority interaction and preparation of Module 4. Management of multiple projects at a time with a focus on budget, timelines and quality. Experienced with establishing and maintaining relationships both within the company and externally to clients. Dedicated team player who is willing to contribute and support fellow colleagues when needed.

Country

Switzerland

City

Zürich Metropolitan Area

Industry

Biotechnology

Skill

Regulatory Affairs, Toxicology, Drug Development, Pharmaceutical Industry, Pharmaceuticals, Regulatory Submissions, IND, Product Development, R&D, In Vivo, Lifesciences, GLP, Pharmacology, Clinical Development, Drug Discovery, CRO, Biopharmaceuticals, Biomarkers, In Vitro, Life Sciences

Experience

sr. Constant Toxicology / preclinical development

ERT consulting GmbH, Toxicology consulting

2023-10 - Present · 3 yrs

Switzerland

sr. Expert Toxicology

NCMA Consulting GmbH

2023-4 - 2024-5 · 1 yr 2 mos

Switzerland

Head of Safety Leaders,

Galapagos

2021-1 - 2023-4 · 2 yrs 4 mos

- Leading the group of safety leaders (project toxicologists) - indications focused on immunology, oncology, infectious diseases - major achievement: implementation of mechanistic toxicology and new assess (organ on a chip) in early drug development / discovery

Head of Toxicology

Galderma

2018-7 - 2021-1 · 2 yrs 7 mos

Vevey

- responsible for all aspects of non-clinical safety (toxicology) - focus on dermatological conditions (immunology), topical and systemic drugs

Sr. Project Toxicologist

Novartis

2008-10 - 2018-6 · 9 yrs 9 mos

Basel Area, Switzerland

-representing pre-clinical safety (toxicology) in crossfunctional project teams -leading dedicated target teams -focus on immunology, infectious diseases, dermatology

Head of Toxicology (Speedel, acquired by Novartis in 2008)

Novartis

2007-1 - 2008-9 · 1 yr 9 mos

Basel Area, Switzerland

-responsible for all aspects of non-clinical safety (toxicology) -major focus on cardiovascular diseases

Associate Director for Preclinical Safety

Arpida AG

2005-10 - 2006-12 · 1 yr 3 mos

- responsible for all aspects of non-clinical safety -major focus on anti-infective

Head of department chronic rodent toxicology (RCC Ltd, acquired by Harlan Laboratories, Inc.)

Harlan Laboratories, Inc.

1998-9 - 2005-9 · 7 yrs 1 mo

Basel Area, Switzerland

DRA Manager

Roche

2000 - 2000

Education

The Julius Maximilians University of Würzburg

Chemistry and Toxicology

1990 - 1998 · 8 yrs

Chemist by training with additional education in toxicology. PhD and post doc theses on metabolism of industrial chamicals in rodents hand human resulting in risk assessments.